Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study aims to assess the efficacy, safety, and PK characteristics of DA-302168S tablets in Chinese T2DM participants, and to provide dose-selection evidence for the Phase III confirmatory trial.

Participants needed: 272
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Chendu DIAO Pharmaceutical Group CO., LTD.Updated: Aug 10, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years (inclusive), both sexes. [+3]

History of type 1 diabetes, diabetes due to pancreatic injury, or other types of... [+15]

Status: Recruiting

A Study of DA-302168S in Participants With Overweight/Obesity

This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study aimed at evaluating the efficacy, safety, and pharmacokinetic (PK) characteristics of DA-302168S tablets in overweight or obese participants in China.

Participants needed: 840
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Chendu DIAO Pharmaceutical Group CO., LTD.Updated: Aug 6, 2026Locations: 1
Eligibility criteria

Age 18-75 years (inclusive), both males and females; [+2]

Type 1 diabetes, type 2 diabetes, or other specific types of diabetes (excluding... [+9]